A method for promoting myelination of an axon comprising administering 4-[.alpha.-hydroxy-5-(1-imidazolyl)-2-methylbenzyl]-3,5-dimethylbenzoic acid is disclosed.
This application is a Divisional application of Ser. No. 09/979,509, filed Mar. 5, 2002, now abandoned which is a 371 of PCT/JP00/03373, filed May 25, 2000.
